High P27 Expression is Associated with a Better Prognosis in East Asian Non-Small Cell Lung Cancer Patients

Yi Zhuang,Hai-Tao Yin,Xia-Li Yin,Jing Wang,De-Ping Zhang
DOI: https://doi.org/10.1016/j.cca.2011.08.018
IF: 6.314
2011-01-01
Clinica Chimica Acta
Abstract:Background: The role of the anti-apoptotic protein p27 in non-small cell lung cancer (NSCLC) remains controversial. To clarify its association with survival in NSCLC, we performed a systematic review of the literature with meta-analysis.Methods: Trials were selected for further analysis if they provided an independent assessment of p27 in NSCLC and reported the analysis of survival data based on p27 status. A total of 11 trials, which comprised 1646 patients, provided sufficient information for the meta-analysis. Sensitivity analyses were conducted using histology, disease stage and ethnicity.Results: The combined hazard ratio (HR) of 1.50 (95% CI = 1.15-1.97; P<0.001 for heterogeneity) suggested that high p27 expression has a favorable impact on survival. When the studies were restricted to those of East Asian populations, patients that expressed high levels of p27 showed a better survival rate (HR 1.73, 95% CI = 1.36-2.21; P = 0.169 for heterogeneity) than those that did not express high levels of p27. In addition, the heterogeneity and publication bias disappeared.Conclusion: In NSCLC, high p27 expression is associated with a better prognosis among East Asians. (C) 2011 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?